-
Journal of Hazardous Materials Oct 2021Plants respond to the limited or excess supply of metalloids, boron (B), silicon (Si), selenium (Se), arsenic (As), and antimony (Sb) via complex signaling pathways that... (Review)
Review
Plants respond to the limited or excess supply of metalloids, boron (B), silicon (Si), selenium (Se), arsenic (As), and antimony (Sb) via complex signaling pathways that are mainly regulated by nitric oxide (NO). The absorption of metalloids from the soil is facilitated by pathways that involve aquaporins, aquaglyceroporins, phosphate, and sulfate transporters; however, their regulation by NO is poorly understood. Using in silico software, we predicted the S-nitrosation of known metalloid transporters, proposing NO-dependent regulation of metalloid transport systems at the posttranslational level. NO intensifies the stress-mitigating effect of Si, whereas in the case of Se, As, and Sb, the accumulation of NO or reactive nitrogen species contributes to toxicity. NO promotes the beneficial effect of low Se concentrations and mitigates the damage caused by B deficiency. In addition, the exogenous application of NO donor, sodium nitroprusside, reduces B, Se, and As toxicity. The primary role of NO in metalloid stress response is to mitigate oxidative stress by activating antioxidant defense at the level of protein activity and gene expression. This review discusses the role of NO in plant responses to metalloids and suggests future research directions.
Topics: Antimony; Arsenic; Metalloids; Nitric Oxide; Plants
PubMed: 34271449
DOI: 10.1016/j.jhazmat.2021.126606 -
Arthritis Research & Therapy Mar 2017Psoriatic arthritis is a part of the family of diseases referred to as spondyloarthropathies, a diverse group of chronic inflammatory disorders with common clinical,... (Review)
Review
Psoriatic arthritis is a part of the family of diseases referred to as spondyloarthropathies, a diverse group of chronic inflammatory disorders with common clinical, radiographic, and genetic features. Peripheral arthritis is the most common symptom of psoriatic arthritis and patients also frequently experience involvement of the entheses, spine, skin, and nails. Due to the diverse clinical spectrum of disease severity, tissues affected, and associated comorbidities, the treatment of psoriatic arthritis can be challenging and it is necessary to mitigate risks associated with both the disease and its treatment. These risks include disease-specific, treatment-related, and psychological risks. Disease-specific risks include those associated with disease progression that can limit functional status and be mitigated through early diagnosis and initiation of treatment. Risks also arise from comorbidities that are associated with psoriatic arthritis such as cardiovascular disease, obesity, diabetes mellitus, and gastrointestinal inflammation. Patient outcomes can be affected by the treatment strategy employed and the pharmacologic agents administered. Additionally, it is important for physicians to be aware of risks specific to each therapeutic option. The impact of psoriatic arthritis is not limited to the skin and joints and it is common for patients to experience quality-of-life impairment. Patients are also more likely to have depression, anxiety, and alcoholism. This article reviews the many risks associated with psoriatic arthritis and provides guidance on mitigating these risks.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Cardiovascular Diseases; Diabetes Mellitus; Gastritis; Humans; Obesity; Risk Assessment; Risk Factors; Skin
PubMed: 28320454
DOI: 10.1186/s13075-017-1265-5 -
Journal of Animal Science May 2019Management and policy decisions are continually made to mitigate disease introductions in animal populations despite often limited surveillance data or knowledge of... (Review)
Review
Management and policy decisions are continually made to mitigate disease introductions in animal populations despite often limited surveillance data or knowledge of disease transmission processes. Science-based management is broadly recognized as leading to more effective decisions yet application of models to actively guide disease surveillance and mitigate risks remains limited. Disease-dynamic models are an efficient method of providing information for management decisions because of their ability to integrate and evaluate multiple, complex processes simultaneously while accounting for uncertainty common in animal diseases. Here we review disease introduction pathways and transmission processes crucial for informing disease management and models at the interface of domestic animals and wildlife. We describe how disease transmission models can improve disease management and present a conceptual framework for integrating disease models into the decision process using adaptive management principles. We apply our framework to a case study of African swine fever virus in wild and domestic swine to demonstrate how disease-dynamic models can improve mitigation of introduction risk. We also identify opportunities to improve the application of disease models to support decision-making to manage disease at the interface of domestic and wild animals. First, scientists must focus on objective-driven models providing practical predictions that are useful to those managing disease. In order for practical model predictions to be incorporated into disease management a recognition that modeling is a means to improve management and outcomes is important. This will be most successful when done in a cross-disciplinary environment that includes scientists and decision-makers representing wildlife and domestic animal health. Lastly, including economic principles of value-of-information and cost-benefit analysis in disease-dynamic models can facilitate more efficient management decisions and improve communication of model forecasts. Integration of disease-dynamic models into management and decision-making processes is expected to improve surveillance systems, risk mitigations, outbreak preparedness, and outbreak response activities.
Topics: African Swine Fever; Agriculture; Animal Diseases; Animals; Animals, Domestic; Animals, Wild; Decision Making; Disease Outbreaks; Disease Reservoirs; Epidemiological Monitoring; Models, Statistical; Risk Assessment; Swine
PubMed: 30976799
DOI: 10.1093/jas/skz125 -
Current Opinion in Organ Transplantation Oct 2021Given recent national attention to the role of racism in perpetuating racial inequities in society and health, this review provides a timely and relevant summary of key... (Review)
Review
PURPOSE OF REVIEW
Given recent national attention to the role of racism in perpetuating racial inequities in society and health, this review provides a timely and relevant summary of key measures of systemic racism in kidney transplantation. More specifically, the review identifies current and promising interventions, whereas highlighting the need for more sustainable and impactful interventions.
RECENT FINDINGS
Racial disparities persist in kidney transplantation. Black and Hispanic individuals are less likely to receive a kidney transplant than non-Hispanic Whites despite disproportionately higher rates of kidney failure. Studies demonstrate that socioeconomic factors do not fully explain existing racial disparities in transplantation. Systemic racism at all levels, individual, interpersonal, institutional, and structural, is at the core of racial disparities, and current interventions are insufficient in mitigating their effects. Thus, targeted and sustainable interventions must be implemented to mitigate systemic racism in kidney transplantation.
SUMMARY
Systemic racism in all its forms continues to influence disparities at all stages of kidney transplantation. This paper highlights recent findings that shed light on how racism contributes to racial disparities in kidney transplantation. Using these findings to identify targets and strategies for mitigation, relevant interventions and policies that show promise are detailed.
Topics: Black or African American; Healthcare Disparities; Hispanic or Latino; Humans; Kidney Transplantation; Racism; United States
PubMed: 34456271
DOI: 10.1097/MOT.0000000000000913 -
Anaesthesia Mar 2024All sectors of society must reduce their carbon footprint to mitigate climate change, and the healthcare community is no exception. This narrative review focuses on the... (Review)
Review
All sectors of society must reduce their carbon footprint to mitigate climate change, and the healthcare community is no exception. This narrative review focuses on the environmental concerns associated with the emissions of volatile anaesthetic agents, some of which are potent greenhouse gases. This review provides an understanding of the global warming potential metric, as well as the concepts of atmospheric lifetime and radiative efficiency. The state of knowledge of the environmental impact and possible climate forcing of emitted volatile anaesthetic agents are reviewed. Additionally, the review discusses how climate metrics can guide mitigation strategies to reduce emissions and suggests present and future options for mitigating the climate impact.
Topics: Humans; Carbon Dioxide; Greenhouse Effect; Anesthetics, Inhalation; Global Warming; Climate Change
PubMed: 38206102
DOI: 10.1111/anae.16119 -
Frontiers in Plant Science 2021The importance of phosphorus in the regulation of plant growth function is well studied. However, the role of the inorganic phosphate (Pi) molecule in the mitigation of... (Review)
Review
The importance of phosphorus in the regulation of plant growth function is well studied. However, the role of the inorganic phosphate (Pi) molecule in the mitigation of abiotic stresses such as drought, salinity, heavy metal, heat, and acid stresses are poorly understood. We revisited peer-reviewed articles on plant growth characteristics that are phosphorus (P)-dependently regulated under the sufficient-P and low/no-P starvation alone or either combined with one of the mentioned stress. We found that the photosynthesis rate and stomatal conductance decreased under Pi-starved conditions. The total chlorophyll contents were increased in the P-deficient plants, owing to the lack of Pi molecules to sustain the photosynthesis functioning, particularly, the Rubisco and fructose-1,6-bisphosphatase function. The dry biomass of shoots, roots, and P concentrations were significantly reduced under Pi starvation with marketable effects in the cereal than in the legumes. To mitigate P stress, plants activate alternative regulatory pathways, the Pi-dependent glycolysis, and mitochondrial respiration in the cytoplasm. Plants grown under well-Pi supplementation of drought stress exhibited higher dry biomass of shoots than the no-P treated ones. The Pi supply to plants grown under heavy metals stress reduced the metal concentrations in the leaves for the cadmium (Cd) and lead (Pb), but could not prevent them from absorbing heavy metals from soils. To detoxify from heavy metal stress, plants enhance the catalase and ascorbate peroxidase activity that prevents lipid peroxidation in the leaves. The and genes were over-expressed under both Pi starvation alone and Pi plus drought, or Pi plus salinity stress combination, implying their key roles to mediate the stress mitigations. Agronomy Pi-based interventions to increase Pi at the on-farm levels were discussed. Revisiting the roles of P in growth and its better management in agricultural lands or where P is supplemented as fertilizer could help the plants to survive under abiotic stresses.
PubMed: 34777404
DOI: 10.3389/fpls.2021.679916 -
Frontiers in Plant Science 2022Abiotic stresses causing extensive yield loss in various crops globally. Over the past few decades, the application of silicon nanoparticles (nSi) has emerged as one of... (Review)
Review
Abiotic stresses causing extensive yield loss in various crops globally. Over the past few decades, the application of silicon nanoparticles (nSi) has emerged as one of the abiotic stress mitigators. The initial responses of plants are shown by the biogenesis of reactive oxygen species (ROS) to sustain cellular/organellar integrity to ensure operation of metabolic functions by regulating physiological and biochemical pathways during stress conditions. Plants have evolved various antioxidative systems to balance/maintain the process of homeostasis enzymatic and non-enzymatic activities to repair the losses. In the adverse environment, supplementation of Si mitigates the stress condition and improved the growth and development of plants. Its ameliorative effects were correlated with the enhanced antioxidant enzymes activities to maintain the equilibrium between the ROS generation and reduction. However, there are limited studies covered the role of nSi in the abiotic stress condition. This review addresses the accumulation and/or uptake of nSi in several crops and its mode of action linked with improved plants' growth and tolerance capabilities to confer sustainable agriculture.
PubMed: 36618645
DOI: 10.3389/fpls.2022.1025974 -
Biofabrication Oct 2022Three-dimensional (3D) bioprinting precisely deposits picolitre bioink to fabricate functional tissues and organs in a layer-by-layer manner. The bioink used for 3D...
Three-dimensional (3D) bioprinting precisely deposits picolitre bioink to fabricate functional tissues and organs in a layer-by-layer manner. The bioink used for 3D bioprinting incorporates living cells. During printing, cells suspended in the bioink sediment to form cell aggregates through cell-cell interaction. The formation of cell aggregates due to cell sedimentation have been widely recognized as a significant challenge to affect the printing reliability and quality. This study has incorporated the active circulation into the bioink reservoir to mitigate cell sedimentation and aggregation. Force and velocity analysis were performed, and a circulation model has been proposed based on iteration algorithm with the time step for each divided region. It has been found that (a) the comparison of the cell sedimentation and aggregation with and without the active bioink circulation has demonstrated high effectiveness of active circulation to mitigate cell sedimentation and aggregation for the bioink with both a low cell concentration of 1 × 10cells mland a high cell concentration of 5 × 10cells ml; and (b) the effect of circulation flow rate on cell sedimentation and aggregation has been investigated, showing that large flow rate results in slow increments in effectiveness. Besides, the predicted mitigation effectiveness percentages on cell sedimentation by the circulation model generally agrees well with the experimental results. In addition, the cell viability assessment at the recommended maximum flow rate of 0.5 ml minhas demonstrated negligible cell damage due to the circulation. The proposed active circulation approach is an effective and efficient approach with superior performance in mitigating cell sedimentation and aggregation, and the resulting knowledge is easily applicable to other 3D bioprinting techniques significantly improving printing reliability and quality in 3D bioprinting.
Topics: Bioprinting; Cell Survival; Printing, Three-Dimensional; Reproducibility of Results; Tissue Engineering; Tissue Scaffolds
PubMed: 36067747
DOI: 10.1088/1758-5090/ac8fb7 -
Philosophical Transactions of the Royal... Dec 2016Amphibians across the planet face the threat of population decline and extirpation caused by the disease chytridiomycosis. Despite consensus that the fungal pathogens... (Review)
Review
Amphibians across the planet face the threat of population decline and extirpation caused by the disease chytridiomycosis. Despite consensus that the fungal pathogens responsible for the disease are conservation issues, strategies to mitigate their impacts in the natural world are, at best, nascent. Reducing risk associated with the movement of amphibians, non-amphibian vectors and other sources of infection remains the first line of defence and a primary objective when mitigating the threat of disease in wildlife. Amphibian-associated chytridiomycete fungi and chytridiomycosis are already widespread, though, and we therefore focus on discussing options for mitigating the threats once disease emergence has occurred in wild amphibian populations. All strategies have shortcomings that need to be overcome before implementation, including stronger efforts towards understanding and addressing ethical and legal considerations. Even if these issues can be dealt with, all currently available approaches, or those under discussion, are unlikely to yield the desired conservation outcome of disease mitigation. The decision process for establishing mitigation strategies requires integrated thinking that assesses disease mitigation options critically and embeds them within more comprehensive strategies for the conservation of amphibian populations, communities and ecosystems.This article is part of the themed issue 'Tackling emerging fungal threats to animal health, food security and ecosystem resilience'.
Topics: Amphibians; Animals; Chytridiomycota; Mycoses
PubMed: 28080996
DOI: 10.1098/rstb.2016.0207 -
The Journal of Pharmacy Technology :... Oct 2022To review the pharmacology, pharmacokinetics, and efficacy and safety data of a combination of olanzapine and samidorphan (OLZ/SAM) for the treatment of schizophrenia... (Review)
Review
OBJECTIVE
To review the pharmacology, pharmacokinetics, and efficacy and safety data of a combination of olanzapine and samidorphan (OLZ/SAM) for the treatment of schizophrenia and bipolar I disorder, which mitigates the possible unwanted side effects of weight gain associated with olanzapine (OLZ).
DATA SOURCES
The review was done with a bibliographic survey of studies using MEDLINE/PubMed (January 1999-May 2021) database using the keywords olanzapine and samidorphan. Abstracts, scientific posters, and information from the manufacturer's product labeling were evaluated for inclusion. Inclusion criteria: phase 2, phase 3, and open-labeled studies that evaluated the use of OLZ/SAM for the treatment of schizophrenia and bipolar I disorder.
DATA SYNTHESIS
We have included one phase 2 dose-ranging exploratory study, two phase 3 efficacy and safety studies, and several open-label extension studies without a comparator. For the treatment of schizophrenia, OLZ/SAM and OLZ alone were analyzed in 2 randomized, double-blind comparison studies of approximately 960 patients. Analysis indicated that OLZ (5-20 mg)/SAM (10 mg) significantly mitigated the side effect of weight gain compared with OLZ alone (control) while maintaining antipsychotic efficacy. For bipolar I disorder, OLZ/SAM was approved as an acute treatment for manic or mixed episodes, as well as an adjunct to valproate or lithium for manic/mixed episodes based on bridging strategy allowed by the Food and Drug Administration.
RELEVANCE TO PATIENT CARE AND CLINICAL PRACTICE
The combination of olanzapine and samidorphan demonstrated efficacy for the treatment of schizophrenia with a dosage range of 5 to 20 mg OLZ to a 10-mg fixed dose of samidorphan. Advantages of this drug combination include once-daily dosing, favorable tolerability, and most importantly, mitigation of weight gain, which may encourage adherence, when compared with OLZ alone.
CONCLUSION
The new combination treatment of OLZ/SAM is a unique antipsychotic formulation to provide the recognized efficacious treatment of OLZ, while mitigating the weight gain and possibly the weight-related adverse effects secondary to OLZ monotherapy.
PubMed: 36046346
DOI: 10.1177/87551225221114281